127 filings
Page 2 of 7
8-K
o9byb5e6 t0bdem
2 May 24
Other Events
7:52am
DEFM14A
l1mq8el7x1
25 Apr 24
Proxy related to merger
4:13pm
DEFA14A
xxtg3c
23 Apr 24
Additional proxy soliciting materials
7:36am
8-K
48x2d0fpmran1n pg
23 Apr 24
Other Events
7:34am
8-K/A
gq4ruy9 5ixk
12 Apr 24
Other Events
5:02pm
PREM14A
e87r8b
10 Apr 24
Preliminary proxy related to merger
4:42pm
8-K
qyamdau nw0avo
9 Apr 24
Other Events
4:10pm
S-8
l6g1kjz 1t
20 Mar 24
Registration of securities for employees
4:30pm
8-K
urxsjm
20 Mar 24
Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates
4:10pm
DFAN14A
gwwwhm9vxj1pepi7
19 Mar 24
Additional proxy materials by non-management
5:27pm
DEFA14A
rfzxm5l p9
19 Mar 24
Additional proxy soliciting materials
6:25am
8-K
4odfxjzoyxq5
19 Mar 24
Voting and Support Agreement
6:24am
8-K
rafa8fxjmhu5xgacwd
16 Feb 24
Entry into a Material Definitive Agreement
4:05pm
8-K
eo84qoa9z
19 Jan 24
Entry into a Material Definitive Agreement
4:13pm
424B5
dyi9y
19 Jan 24
Prospectus supplement for primary offering
4:10pm
8-K
imhn0xp xyd3b
4 Jan 24
Fusion Pharmaceuticals Announces Clinical Program and Manufacturing Updates
4:31pm
8-K
x04du7bz
7 Nov 23
Fusion Pharmaceuticals Announces Third Quarter 2023 Financial Results and Clinical Program Updates
7:45am